134 related articles for article (PubMed ID: 1861629)
1. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients.
Lavy A; Brook GJ; Dankner G; Ben Amotz A; Aviram M
Metabolism; 1991 Aug; 40(8):794-9. PubMed ID: 1861629
[TBL] [Abstract][Full Text] [Related]
2. Effect of cholesterol feeding on the susceptibility of lipoproteins to oxidative modification.
Nenseter MS; Gudmundsen O; Malterud KE; Berg T; Drevon CA
Biochim Biophys Acta; 1994 Jul; 1213(2):207-14. PubMed ID: 8025132
[TBL] [Abstract][Full Text] [Related]
3. Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies.
Aviram M; Dankner G; Cogan U; Hochgraf E; Brook JG
Metabolism; 1992 Mar; 41(3):229-35. PubMed ID: 1542259
[TBL] [Abstract][Full Text] [Related]
4. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of dietary capsaicin on induced oxidation of low-density lipoprotein in rats.
Kempaiah RK; Manjunatha H; Srinivasan K
Mol Cell Biochem; 2005 Jul; 275(1-2):7-13. PubMed ID: 16335782
[TBL] [Abstract][Full Text] [Related]
6. The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients.
Cominacini L; Pastorino AM; Garbin U; Campagnola M; de Santis A; Davoli A; Faccini G; Bertozzo L; Pasini F; Pasini AF
Nutrition; 1994; 10(6):527-31. PubMed ID: 7703599
[TBL] [Abstract][Full Text] [Related]
7. [Predisposition to in vitro oxidation of LDL isolated from hypercholesterolemic patients. Interaction with arterial proteoglycans].
Barón L; López F
Acta Cient Venez; 1999; 50(1):1-10. PubMed ID: 10513033
[TBL] [Abstract][Full Text] [Related]
8. In vivo clearance of low-density lipoproteins and beta-very-low-density lipoproteins in normal and hypercholesterolemic White Carneau pigeons.
Reagan JW; St Clair RW
Biochim Biophys Acta; 1991 Jan; 1081(2):202-10. PubMed ID: 1998739
[TBL] [Abstract][Full Text] [Related]
9. Role of ascorbic acid on in vitro oxidation of low-density lipoprotein derived from hypercholesterolemic patients.
Das S; Snehlata ; Das N; Srivastava LM
Clin Chim Acta; 2006 Oct; 372(1-2):202-5. PubMed ID: 16701604
[TBL] [Abstract][Full Text] [Related]
10. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
Lee HS; Jeong JY; Kim BC; Kim YS; Zhang YZ; Chung HK
Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281
[TBL] [Abstract][Full Text] [Related]
11. Valsartan therapy has additive anti-oxidative effect to that of fluvastatin therapy against low-density lipoprotein oxidation: studies in hypercholesterolemic and hypertensive patients.
Hussein O; Shneider J; Rosenblat M; Aviram M
J Cardiovasc Pharmacol; 2002 Jul; 40(1):28-34. PubMed ID: 12072574
[TBL] [Abstract][Full Text] [Related]
12. Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease.
Chiu HC; Jeng JR; Shieh SM
Biochim Biophys Acta; 1994 Jan; 1225(2):200-8. PubMed ID: 8280789
[TBL] [Abstract][Full Text] [Related]
13. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic.
Fuhrman B; Volkova N; Rosenblat M; Aviram M
Antioxid Redox Signal; 2000; 2(3):491-506. PubMed ID: 11229363
[TBL] [Abstract][Full Text] [Related]
14. Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolemia treated by LDL apheresis.
Bräutigam C; Engelmann B; Reiss D; Reinhardt U; Thiery J; Richter WO; Brosche T
Atherosclerosis; 1996 Jan; 119(1):77-88. PubMed ID: 8929259
[TBL] [Abstract][Full Text] [Related]
15. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.
Napoli C; D'Armiento FP; Mancini FP; Postiglione A; Witztum JL; Palumbo G; Palinski W
J Clin Invest; 1997 Dec; 100(11):2680-90. PubMed ID: 9389731
[TBL] [Abstract][Full Text] [Related]
16. The rebound of lipoproteins after LDL-apheresis. Effects on chemical composition and LDL-oxidizability.
Kroon AA; Demacker PN; Kleinveld HA; Stalenhoef AF
Atherosclerosis; 1999 Nov; 147(1):105-13. PubMed ID: 10525131
[TBL] [Abstract][Full Text] [Related]
17. Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL.
Hussein O; Schlezinger S; Rosenblat M; Keidar S; Aviram M
Atherosclerosis; 1997 Jan; 128(1):11-8. PubMed ID: 9051193
[TBL] [Abstract][Full Text] [Related]
18. Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation.
Aviram M; Eias K
Ann Nutr Metab; 1993; 37(2):75-84. PubMed ID: 8517637
[TBL] [Abstract][Full Text] [Related]
19. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
Stalenhoef AF; de Graaf J; Wittekoek ME; Bredie SJ; Demacker PN; Kastelein JJ
Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of plasma lipoproteins in the genetically hypercholesterolemic rat (RICO).
Ouguerram K; Magot T; Lutton C
Metabolism; 1996 Jan; 45(1):4-11. PubMed ID: 8544775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
